nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.701	1	CbGbCtD
Palonosetron—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.017	0.0603	CcSEcCtD
Palonosetron—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0377	CcSEcCtD
Palonosetron—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0377	CcSEcCtD
Palonosetron—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00995	0.0353	CcSEcCtD
Palonosetron—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00893	0.0317	CcSEcCtD
Palonosetron—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00819	0.0291	CcSEcCtD
Palonosetron—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00786	0.0279	CcSEcCtD
Palonosetron—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0078	0.0277	CcSEcCtD
Palonosetron—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.007	0.0249	CcSEcCtD
Palonosetron—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.00688	0.399	CbGeAlD
Palonosetron—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00644	0.0229	CcSEcCtD
Palonosetron—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0225	CcSEcCtD
Palonosetron—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00628	0.0223	CcSEcCtD
Palonosetron—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.006	0.0213	CcSEcCtD
Palonosetron—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00543	0.0193	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0168	CcSEcCtD
Palonosetron—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00436	0.0155	CcSEcCtD
Palonosetron—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00418	0.0148	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0147	CcSEcCtD
Palonosetron—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00406	0.0144	CcSEcCtD
Palonosetron—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00399	0.0142	CcSEcCtD
Palonosetron—HTR3A—nerve—amyotrophic lateral sclerosis	0.00352	0.204	CbGeAlD
Palonosetron—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00334	0.0119	CcSEcCtD
Palonosetron—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0118	CcSEcCtD
Palonosetron—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0118	CcSEcCtD
Palonosetron—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.0115	CcSEcCtD
Palonosetron—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00313	0.0111	CcSEcCtD
Palonosetron—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00312	0.0111	CcSEcCtD
Palonosetron—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0111	CcSEcCtD
Palonosetron—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00297	0.0105	CcSEcCtD
Palonosetron—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0105	CcSEcCtD
Palonosetron—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0102	CcSEcCtD
Palonosetron—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00287	0.0102	CcSEcCtD
Palonosetron—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0102	CcSEcCtD
Palonosetron—Chills—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0101	CcSEcCtD
Palonosetron—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00284	0.0101	CcSEcCtD
Palonosetron—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00996	CcSEcCtD
Palonosetron—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00988	CcSEcCtD
Palonosetron—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00981	CcSEcCtD
Palonosetron—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00967	CcSEcCtD
Palonosetron—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00961	CcSEcCtD
Palonosetron—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00907	CcSEcCtD
Palonosetron—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00239	0.0085	CcSEcCtD
Palonosetron—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00847	CcSEcCtD
Palonosetron—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00836	CcSEcCtD
Palonosetron—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00836	CcSEcCtD
Palonosetron—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00833	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00234	0.0083	CcSEcCtD
Palonosetron—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00825	CcSEcCtD
Palonosetron—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00817	CcSEcCtD
Palonosetron—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00801	CcSEcCtD
Palonosetron—Infection—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00796	CcSEcCtD
Palonosetron—Shock—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00788	CcSEcCtD
Palonosetron—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00785	CcSEcCtD
Palonosetron—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00782	CcSEcCtD
Palonosetron—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00778	CcSEcCtD
Palonosetron—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00763	CcSEcCtD
Palonosetron—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00748	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00205	0.0073	CcSEcCtD
Palonosetron—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00724	CcSEcCtD
Palonosetron—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00719	CcSEcCtD
Palonosetron—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00714	CcSEcCtD
Palonosetron—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.002	0.00712	CcSEcCtD
Palonosetron—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00705	CcSEcCtD
Palonosetron—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00696	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00691	CcSEcCtD
Palonosetron—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00691	CcSEcCtD
Palonosetron—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00685	CcSEcCtD
Palonosetron—Pain—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00685	CcSEcCtD
Palonosetron—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00655	CcSEcCtD
Palonosetron—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00633	CcSEcCtD
Palonosetron—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00633	CcSEcCtD
Palonosetron—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0059	CcSEcCtD
Palonosetron—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00575	CcSEcCtD
Palonosetron—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00567	CcSEcCtD
Palonosetron—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00548	CcSEcCtD
Palonosetron—HTR3A—brainstem—amyotrophic lateral sclerosis	0.00151	0.0877	CbGeAlD
Palonosetron—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00149	0.0053	CcSEcCtD
Palonosetron—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00509	CcSEcCtD
Palonosetron—Rash—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00505	CcSEcCtD
Palonosetron—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00505	CcSEcCtD
Palonosetron—Headache—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00502	CcSEcCtD
Palonosetron—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00476	CcSEcCtD
Palonosetron—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00097	0.0562	CbGeAlD
Palonosetron—HTR3A—nervous system—amyotrophic lateral sclerosis	0.000793	0.0459	CbGeAlD
Palonosetron—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.000763	0.0442	CbGeAlD
Palonosetron—HTR3A—brain—amyotrophic lateral sclerosis	0.000606	0.0351	CbGeAlD
Palonosetron—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000556	0.0322	CbGeAlD
Palonosetron—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000296	0.0172	CbGeAlD
Palonosetron—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000291	0.0169	CbGeAlD
Palonosetron—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000285	0.0165	CbGeAlD
Palonosetron—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000281	0.0163	CbGeAlD
Palonosetron—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000274	0.0159	CbGeAlD
Palonosetron—CYP2D6—brain—amyotrophic lateral sclerosis	0.000223	0.0129	CbGeAlD
